Other OTC - Delayed Quote USD

Excellerant, Inc. (EXCL)

0.0000 0.0000 (0.00%)
At close: March 4 at 3:35 PM EST
Loading Chart for EXCL
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0006
  • Volume 3
  • Avg. Volume 0
  • Market Cap (intraday) 5
  • Beta (5Y Monthly) 2.53
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients. Further, it provides information related to transportation and medical institutions. The company was incorporated in 2019 and is based in Brussels, Belgium. Excellerant, Inc. is a subsidiary of Swamson Capital AG.

excellerant.vc

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EXCL

Performance Overview: EXCL

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EXCL
99.50%
S&P 500
9.49%

1-Year Return

EXCL
99.00%
S&P 500
26.79%

3-Year Return

EXCL
100.00%
S&P 500
23.39%

5-Year Return

EXCL
--
S&P 500
33.47%

Compare To: EXCL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EXCL

Valuation Measures

Annual
As of 12/1/2023
  • Market Cap

    1.13k

  • Enterprise Value

    15.06k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -13.8k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: EXCL

Company Insights: EXCL

Research Reports: EXCL

People Also Watch